We are live on ! Find out more
NA

Nordwand Advisors Portfolio holdings

AUM $572M
1-Year Est. Return 23.09%
This Fund
S&P 500
This Quarter Est. Return
-1.46%
1 Year Est. Return
+23.09%
3 Year Est. Return
+66.91%
5 Year Est. Return
10 Year Est. Return
AUM
$229M
AUM Growth
-$28.1M
Cap. Flow
-$23.6M
Cap. Flow %
-10.29%
Top 10 Hldgs %
92.99%
Holding
182
New
23
Increased
8
Reduced
24
Closed
31

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.69M
2
HUBB icon
Hubbell
HUBB
+$1.45M
3
UBS icon
UBS Group
UBS
+$1.43M
4
KB icon
KB Financial Group
KB
+$1.33M
5
AVGO icon
Broadcom
AVGO
+$1.3M

Sector Composition

Rank Sector Weight
1 Financials 46.91%
2 Healthcare 33.13%
3 Technology 7.71%
4 Consumer Discretionary 1.86%
5 Materials 0.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHX icon
126
DHI Group
DHX
$182M
$4.18K ﹤0.01%
+2,000
New +$4.64K
SLE icon
127
Super League Enterprise
SLE
$4.28M
$4K ﹤0.01%
+10
New +$6.43K
TSBX
128
DELISTED
Turnstone Biologics
TSBX
$3.93K ﹤0.01%
+1,500
New +$4.29K
XLP icon
129
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$3.83K ﹤0.01%
50
BIL icon
130
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$3.58K ﹤0.01%
39
SEER icon
131
Seer Inc
SEER
$122M
$3.36K ﹤0.01%
+2,000
New +$3.73K
SLDP icon
132
Solid Power
SLDP
$463M
$3.3K ﹤0.01%
+2,000
New +$3.45K
PMVP icon
133
PMV Pharmaceuticals
PMVP
$59.2M
$3.24K ﹤0.01%
+2,000
New +$3.61K
LVO icon
134
LiveOne
LVO
$61.7M
$3.14K ﹤0.01%
+200
New +$3.54K
GGR icon
135
Gogoro
GGR
$50.8M
$3.08K ﹤0.01%
+100
New +$3.08K
MRSN
136
DELISTED
Mersana Therapeutics
MRSN
$3.02K ﹤0.01%
+60
New +$4.34K
IMRX icon
137
Immuneering
IMRX
$267M
$2.56K ﹤0.01%
+2,000
New +$3.29K
AMPX icon
138
Amprius Technologies
AMPX
$1.36B
$2.54K ﹤0.01%
+2,000
New +$3.26K
VOO icon
139
Vanguard S&P 500 ETF
VOO
$979B
$2.5K ﹤0.01%
5
CRNT icon
140
Ceragon Networks
CRNT
$197M
$2.5K ﹤0.01%
+1,000
New +$2.73K
FTSM icon
141
First Trust Enhanced Short Maturity ETF
FTSM
$6.49B
$2.38K ﹤0.01%
40
ALLO icon
142
Allogene Therapeutics
ALLO
$649M
$2.33K ﹤0.01%
+1,000
New +$2.95K
RVSN icon
143
Rail Vision
RVSN
$8.79M
$2.22K ﹤0.01%
+100
New +$3.3K
ARKK icon
144
ARK Innovation ETF
ARKK
$5.66B
$2.2K ﹤0.01%
50
XPEV icon
145
XPeng
XPEV
$12.4B
$1.47K ﹤0.01%
200
DRRX
146
DELISTED
DURECT Corp
DRRX
$1.29K ﹤0.01%
+1,000
New +$1.18K
VO icon
147
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$1.21K ﹤0.01%
20
INTZ
148
Intrusion
INTZ
$17.5M
$1.1K ﹤0.01%
+1,000
New +$1.82K
VB icon
149
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$654 ﹤0.01%
3
BNBX
150
DELISTED
BNB PLUS CORP
BNBX
$408 ﹤0.01%
+1
New +$2.56K

Similar funds

Nordwand Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Nordwand Advisors held 182 positions worth $229M, down 11% from $257M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Nordwand Advisors withdrew a net $23.6M in Q2 2024, closing 31 positions and reducing 24 holdings. Its most notable exit was UBS Group, an estimated $1.43M position sold in full.

By sector, the portfolio is most concentrated in Financials at 47% of assets, up from 44% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Nordwand Advisors opened a new position in Honda worth $228K.

  • Nordwand Advisors's largest Q2 2024 buy was Honda: 7,059 shares worth $228K.
  • Nordwand Advisors added most to Philip Morris in Q2 2024, an estimated $229K increase.
  • Nordwand Advisors's biggest Q2 2024 reduction was Microsoft, cutting an estimated $1.69M.
  • Nordwand Advisors fully exited UBS Group in Q2 2024, selling an estimated $1.43M.
  • Nordwand Advisors's ten largest holdings make up 93% of its $229M portfolio in Q2 2024.
  • Nordwand Advisors opened 23 new positions and closed 31 in Q2 2024.
  • Nordwand Advisors's portfolio value fell 11% quarter-over-quarter to $229M.

Based on Nordwand Advisors's 13F filing for Q2 2024, filed 5 Aug 2024.